Metaanalysis vs large clinical trials: which should guide our management?

American Journal of Obstetrics and Gynecology

Volumn 200, Issue 5, 2009, Pages 484.e1-484.e5

  Scifres, Christina M ^a   Iams, Jay D ^b   Klebanoff, Mark ^c   Macones, George A ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

metaanalysis; randomized clinical trial

Indexed keywords

ACETYLSALICYLIC ACID; CALCIUM;

ARTICLE; CALCIUM INTAKE; CLINICAL PRACTICE; CLINICAL TRIAL; CONSENSUS; DRUG EFFICACY; EVIDENCE BASED PRACTICE; HUMAN; LOW DRUG DOSE; META ANALYSIS; METHODOLOGY; OUTCOME ASSESSMENT; PATIENT CARE; PRACTICE GUIDELINE; PREECLAMPSIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK REDUCTION; SAMPLE SIZE; SUPPLEMENTATION;

EID: 64249122510     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2008.09.873     Document Type: Article

References (25)

1. Redman C.W., and Sargent I.L. Latest advances in understanding pre-eclampsia. Science 308 (2005) 1592-1594
2. Levine R.J., Maynard S.E., Qian C., et al. Circulating angiogenic factors and the risk of pre-eclampsia. N Engl J Med 350 (2004) 672-683
3. Bussolino F., Benedetto C., Massobrio M., and Camussi G. Maternal vascular prostacyclin activity in pre-eclampsia. Lancet 2 (1980) 702
4. Masotti G., Galanti G., Poggesi L., et al. Differential inhibition of prostacyclin production and platelet aggregation by aspirin. Lancet 2 (1979) 1213-1217
5. Belizan J.M., and Villar J. The relationship between calcium intake and edema, proteinuria, and hypertension-gestosis: a hypothesis. Am J Clin Nutr 33 (1980) 2202-2210
6. Belizan J.M., Villar J., and Repke J. The relationship between calcium intake and pregnancy-induced hypertension: up-to-date evidence. Am J Obstet Gynecol 1598 (1988) 898-902
7. Kincaid-Smith P., North R.A., Fairly K.F., et al. Prevention of pre-eclampsia in women with renal disease: a prospective randomized trial of heparin and dipyridamole. Nephrology 1 (1995) 297-300
8. CLASP (Collaborative Low-dose Aspirin Study in Pregnancy) Collaborative Group. CLASP: a randomized trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women. Lancet 343 (1994) 619-629
9. Niromanesh S., Laghii S., and Mosavi-Jarrahi A. Supplementary calcium in prevention of pre-eclampsia. Int J Obstet Gynecol 74 (2001) 17-21
10. Villar J., Abdel-Aleem H., Merialdi M., et al. World Health Organization randomized trial of calcium supplementation among low calcium intake pregnant women. Am J Obstet Gynecol 194 (2006) 639-649
11. Sibai B.M., Caritis S.N., Thom E., et al. Prevention of pre-eclampsia with low-dose aspirin in healthy, nulliparous pregnant women. N Engl J Med 329 (1993) 1213-1218
12. Caritis S., Sibai B., Hauth J., et al. Low-dose aspirin to prevent pre-eclampsia in women at high risk. N Engl J Med 338 (1998) 701-705
13. Golding J. A randomized trial of low dose aspirin for primiparae in pregnancy. BJOG 105 (1998) 293-299
14. Rotchell Y.E., Cruickshank J.K., Phillips Gay M., et al. Barbados low dose aspiring study in pregnancy (BLASP): a randomized trial for the prevention of pre-eclampsia and its complications. BJOG 105 (1998) 286-292
15. Askey L.M., Duley L., Henderson-Smart D.J., Stewart L.A., and PARIS Collaborative Group. Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data. Lancet 369 (2007) 1791-1798
16. Duley L., Henderson-Smart D.J., Meher S., and King J.F. Antiplatelet agents for prevention of pre-eclampsia and its complications. Cochrane Database Syst Rev (2007) CD004659
17. Levine R.J., Hauth J.C., Curet L.B., et al. Trial of calcium to prevent pre-eclampsia. N Engl J Med 337 (1997) 69-76
18. Hofmeyer G.J., Atallah A.N., and Duley L. Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems. Cochrane Database Syst Rev (2006) CD001059
19. Easterbrook P.S., Berlin J.A., Gopalan R., and Matthews D.R. Publication bias in clinical research. Lancet 337 (1991) 867-872
20. In: Higgins J.P.T., and Green S. (Eds). Cochrane handbook for systematic reviews of interventions, version 5.0.0 (updated February 2008): the Cochrane collaboration (2008). http://www.cochrane-handbook.org Available at: www.cochrane-handbook.org. Accessed Aug. 1, 2008.
21. Stewart L.A., Clard M.J., and Cochrane working group on meta-analysis using individual patient data. Practical methodology of meta-analysis using updated individual patient data. Stat Med 14 (1995) 2057-2079
22. Simmonds M.C., Higgins J.P., Stewart L.A., et al. Meta-analysis of individual patient data from randomized trials: a review of methods used in practice. Clin Trial 2 (2005) 209-217
23. Schulz K.F., Chalmers I., Hayes R.J., and Altman D.G. Empirical estimates of bias: dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 273 (1995) 408-412
24. Moher D., Cook D.J., Eastwood S., et al. Improving the quality of reports of meta-analyses of randomized controlled trials: the QUOROM statement. Lancet 354 (1999) 1896-1900
25. LeLorier J., Gregoire G., Benhaddad A., et al. Discrepancies between meta-analysis and subsequent large randomized, controlled trials. N Engl J Med 337 (1997) 536-542